Strong antibody response and nasal cytokines may protect young children from severe COVID-19

New research helps explain why young children have lower rates of severe COVID-19 than adults. A study of infants and young children found those who acquired SARS-CoV-2 had a strong, sustained antibody response to the virus and high levels of inflammatory proteins in the nose but not in the blood.

Nektar divests manufacturing site and reagent arm for $90M

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 6, 2024

Bob Langer, Flagship’s Stephen Berenson to depart Moderna’s board as Carlyle co-founder joins

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 24, 2024

New frailty index helps predict hospitalization and death risks in older adults

Investigators at Mass General Brigham have developed a tool that can identify older adults at increased risk of emergency healthcare needs, rehospitalization or death.

February 21, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.